HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-(N-hydroxyamidino)piperidine

structure given in first source; used as a model for the oxidation of N(omega)-hydroxy-L-arginine by nitric oxide synthase

Also Known As:

NHAP-N

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amidines: 14
  - N-(N-hydroxyamidino)piperidine: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - N-(N-hydroxyamidino)piperidine: 1

Experts

1.	Fujii, Hiroshi: 1 article (05/2009)
2.	Kaneda, Toshihiko: 1 article (05/2009)
3.	Kaneko, Masahiro: 1 article (05/2009)
4.	Kubota, Mio: 1 article (05/2009)
5.	Tani, Shigenori: 1 article (05/2009)
6.	Tomioka, Hiromi: 1 article (05/2009)

Related Diseases

1.

Pneumonia (Pneumonitis)

05/01/2009 - "Patients with NHAP (n = 147) were significantly older (85.8 +/- 8.0 years vs. 80.2 +/- 8.2 years); predominantly female (57.1% vs. 41.5%); had higher severity (the 2005 Japanese Respiratory Society guidelines A-DROP score: 2.5 +/- 1.1 vs. 2.1 +/- 1.2) and a higher mortality (10.4% vs. 5.8%); had a longer median length of hospital stay (17 days vs. 15 days) than elderly patients with community-acquired pneumonia (n = 545). "

Related Therapies and Procedures

1.	Length of Stay